'Do you need to do surgery?' Oncologist see a potential milestone in breast-cancer treatment
When Sabrina Jones was diagnosed with aggressive breast cancer, she expected to have surgery to remove the tumor—and her entire breast.But the 52-year-old manager at an educational-tech company responded so well to chemotherapy, her surgeon at the University of Texas.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US Aid Cuts Are Making It Harder For Palestinian Women To Treat Their Breast CancerMore than 1,000 women who had mammograms done through a US-funded program and were flagged for follow-ups have had to seek other treatment options.
Read more »
Roche's Tecentriq wins U.S. approval for aggressive breast cancerRoche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...
Read more »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Read more »
Roche's Tecentriq notches win in breast cancer with U.S. approvalRoche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...
Read more »
Fast-Growth Chickens Produce New Industry Woe: ‘Spaghetti Meat’The poultry industry faces product problems arising from birds bred for fast growth: Texture so squishy it’s called “spaghetti meat,” or so leathery it's called 'woody breast'
Read more »
US Aid Cuts Are Making It Harder For Palestinian Women To Treat Their Breast CancerMore than 1,000 women who had mammograms done through a US-funded program and were flagged for follow-ups have had to seek other treatment options.
Read more »
Roche's Tecentriq wins U.S. approval for aggressive breast cancerRoche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...
Read more »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Read more »